Skip to main navigation
Orchestra BioMed logo

Close

Investor Relations
  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • Investor Relations
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & Filings
    • SEC Filings
    • Annual Reports and Proxy Satements
  • IR Resources
    • Email Alerts
    • Contact IR
  • Contact Us
Menu - sns
Twitter Linkedin

Investor Relations

SEC Filings

Filing date Form Description Filing Group View
Jun 22, 2020 DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Registration Statements
View HTML
0001213900-20-015488.pdf
0001213900-20-015488.rtf
0001213900-20-015488.xls
Jul 17, 2020 S-1

Registration statement for face-amount certificate companies

Registration Statements
View HTML
0001213900-20-017800.pdf
0001213900-20-017800.rtf
0001213900-20-017800.xls
Jul 24, 2020 S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
0001213900-20-018584.pdf
0001213900-20-018584.rtf
0001213900-20-018584.xls
Jul 28, 2020 S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
0001213900-20-018906.pdf
0001213900-20-018906.rtf
0001213900-20-018906.xls
Jul 30, 2020 CORRESP

CORRESP

Other
View HTML
0001213900-20-019305.pdf
0001213900-20-019305.rtf
0001213900-20-019305.xls
Jul 30, 2020 CORRESP

CORRESP

Other
View HTML
0001213900-20-019290.pdf
0001213900-20-019290.rtf
0001213900-20-019290.xls
Aug 03, 2020 8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML
0001213900-20-019874.pdf
0001213900-20-019874.rtf
0001213900-20-019874.xls
Aug 03, 2020 S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

Registration Statements
View HTML
0001213900-20-019997.pdf
0001213900-20-019997.rtf
0001213900-20-019997.xls
Aug 03, 2020 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
0001213900-20-019998.pdf
0001213900-20-019998.rtf
0001213900-20-019998.xls
Aug 03, 2020 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
0001213900-20-019999.pdf
0001213900-20-019999.rtf
0001213900-20-019999.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 124 results

Data provided by Kaleidoscope.

Orchestra BioMed logo
  • Footerlink - who we are

    Who We Are Our Approach Our People Careers
  • Footerlink - our innovations

    Our Innovations Pipeline Therapeutic Areas Virtue® SAB BackBeat CNT™ FreeHold Retractors
  • Footerlink - news & events

    Investor Relations Overview News & Events Stock Information Corporate Governance Financial & Filings IR Resources
  • Footerlink - contact us

    Contact Us
Menu - sns
Twitter Linkedin

© 2023 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Btn - disclaimer

Disclaimer